Patents Assigned to IDI Farmaceutici S.p.A.
  • Dietary product effective to combat oxidative stress and cell decay
    Patent number: 6303139
    Abstract: The present invention relates to a dietary product comprising ubiquinone, stabilized vitamin E, phospholipids, selenuim in an organic form and L-methionin, which is effective to combat cell oxidative stress even to the extreme consequences thereof, for example cell decay, acquired and/or congenital immunodeficiency or other alterations in the immune system. The dietary product object of the present invention is also effective as a coadjutant in the treatment of apoptosis, in mutagenesis and/or carcinogenesis, in infectious diseases of viral or bacterial origin or those deriving from other external pathogens, in myelinic and skin diseases, in cardiovascular diseases and in allergies.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: October 16, 2001
    Assignee: IDI Farmaceutici S.p.A.
    Inventors: Siro Passi, Decimo Guarnieri, Santo Carbone
  • Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
    Patent number: 6127417
    Abstract: New stable derivatives of ubiquinole are described, having general formula (I), along with processes for their production and their pharmaceutical use, in particular in the treatment of intracellular oxidative stress and diseases involving oxidative stress of this kind.
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: October 3, 2000
    Assignee: IDI Farmaceutici S.p.A.
    Inventors: Decimo Guarnieri, Santo Carbone, Siro Passi